Introduction
Introduction
Gain new KOL insights on the latest events happening in Ulcerative Colitis. Topics covered include opinions regarding Phase III data on Johnson & Johnson’s Stelara (ustekinumab) in Crohn’s disease and the launch of a new study looking at use of the therapy in patients with UC; the recent filing in the US and EU for Amgen’s ABP 501 (a proposed adalimumab biosimilar); the FDA advisory committee’s decision to recommend approval of Celltrion’s CT-P13 (a proposed infliximab biosimilar); as well as opinions on the early development of both Qu Biologics’ QBECO and Protagonist Therapeutics’ PTG 100.
Key Questions Answered in this Update Bulletin:
Update Bulletins include expert insight and analysis based on FirstWord analyst re-engagement with the KOLs after major events such as product approvals, key data releases and major conferences to deliver the most valuable insights with each update.
Table of Contents
for Ulcerative Colitis: Update Bulletin [Feb 2016]
Additional Details
Publisher
FirstWord Pharma
Publisher Information
Reference
301 |
Report Format
Related Reports
| Title | Date Published | Price from | More Details |
|---|---|---|---|
| SAVE 15% today! Ulcerative Colitis - Pipeline Review, H1 2017 Ulcerative Colitis - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical an... | 09 May 2017 by Global Markets Direct | USD $1,700 (normally USD $2,000) |
More Info |
| SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2017 The Global Ulcerative Colitis Partnering Terms and Agreements since 2010 report provides understandi... | 01 Apr 2017 by Current Partnering | USD $1,271 (normally USD $1,495) |
More Info |
| SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2017 The Global Ulcerative Colitis Partnering Terms and Agreements since 2010 report provides understandi... | 01 Feb 2017 by Current Partnering | USD $1,271 (normally USD $1,495) |
More Info |
| SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2016 The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce... | 01 Nov 2016 by Current Partnering | USD $1,271 (normally USD $1,495) |
More Info |
| SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2016 The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce... | 01 Oct 2016 by Current Partnering | USD $1,271 (normally USD $1,495) |
More Info |
| SAVE 15% today! Ulcerative Colitis Global Clinical Trials Review, H2, 2016 Ulcerative Colitis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report,... | 28 Sep 2016 by Global Data | USD $2,125 (normally USD $2,500) |
More Info |
| SAVE 15% today! Ulcerative Colitis: KOL Insight Are UC biosimilars a real or perceived threat to branded drugs?Ulcerative colitis (UC) treatment is ... | 01 Sep 2016 by FirstWord Pharma | USD $6,715 (normally USD $7,900) |
More Info |
| SAVE 15% today! Adalimumab Market Analysis: by Applications (Rheumatoid Arthritis, Psoriasis, Crohn’s Disease, Ulcerative Colitis, and Others) and Geography – Forecast 2016-2021 Adalimumab, which is a patent product of the Abott Biotechnology Ltd., is a medication used for trea... | 11 Mar 2016 by | USD $5,250 (normally USD $6,176) |
More Info |
| SAVE 15% today! Ulcerative Colitis: KOL Insight Introductionipeline drugs are poised to reshape the way doctors treat ulcerative colitis (UC). But w... | 01 Dec 2015 by FirstWord Pharma | USD $6,715 (normally USD $7,900) |
More Info |
| SAVE 15% today! Ulcerative Colitis: KOL Insight IntroductionThe Ulcerative Colitis (UC) treatment market is already undergoing radical change as new... | 03 Dec 2014 by FirstWord Pharma | USD $6,715 (normally USD $7,900) |
More Info |
This report is published by FirstWord Pharma
Download Free Report Summary PDF
![Ulcerative Colitis: Update Bulletin [Feb 2016] | Download PDF Summary](img/xpdf-summary.jpg.pagespeed.ic.PvEUQqtmCi.jpg "Ulcerative Colitis: Update Bulletin <br/>[Feb 2016] | Download PDF Summary")
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Ordering Information
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.